Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumoral microenvironment prevents de novo asparagine biosynthesis in B cell lymphoma, regardless of ASNS expression
Manuel Grima-Reyes, Ashaina Vandenberghe, Ivan Nemazanyy, et al.
Science Advances (2022) Vol. 8, Iss. 27
Open Access | Times Cited: 21

Showing 21 citing articles:

Asparagine restriction enhances CD8+ T cell metabolic fitness and antitumoral functionality through an NRF2-dependent stress response
JN Rashida Gnanaprakasam, Bhavana Kushwaha, Lingling Liu, et al.
Nature Metabolism (2023) Vol. 5, Iss. 8, pp. 1423-1439
Open Access | Times Cited: 49
Metabolism of asparagine in the physiological state and cancer
Qiong Yuan, Liyang Yin, Jun He, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 19
The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy
Qinglong Ma, Wenyang Zhang, Kongming Wu, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Tumor-induced metabolic immunosuppression: Mechanisms and therapeutic targets
Jean‐Ehrland Ricci
Cell Reports (2025) Vol. 44, Iss. 1, pp. 115206-115206
Closed Access | Times Cited: 3
A metabolic synthetic lethality of phosphoinositide 3-kinase-driven cancer
Guillaume P. Andrieu, Mathieu Simonin, Aurélie Cabannes‐Hamy, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
L-asparaginase anti-tumor activity in pancreatic cancer is dependent on its glutaminase activity and resistance is mediated by glutamine synthetase
Jonathan Blachier, Aurore Cleret, Nathalie Guérin, et al.
Experimental Cell Research (2023) Vol. 426, Iss. 2, pp. 113568-113568
Closed Access | Times Cited: 16
The combination of calreticulin-targeting L-ASNase and anti-PD-L1 antibody modulates the tumor immune microenvironment to synergistically enhance the antitumor efficacy of radiotherapy
Ying Zhang, V. Akhil, Ho Seong Seo, et al.
Theranostics (2024) Vol. 14, Iss. 3, pp. 1195-1211
Open Access | Times Cited: 4
Serum NMR Metabolomics in Distinct Subtypes of Hematologic Malignancies
Ayşe Zehra Gül, Şahabettin Selek, Somer Bekiroğlu, et al.
Experimental Hematology (2025), pp. 104710-104710
Closed Access
Sex-specific effects of exogenous asparagine on colorectal tumor growth, 17β-estradiol levels, and aromatase
Oladimeji Aladelokun, Katherine Benitez, Yuying Wang, et al.
Pharmacological Research (2025), pp. 107736-107736
Open Access
The SLC38A5/SNAT5 amino acid transporter: from pathophysiology to pro-cancer roles in the tumor microenvironment
Giuseppe Taurino, Martina Chiu, Massimiliano G. Bianchi, et al.
AJP Cell Physiology (2023) Vol. 325, Iss. 2, pp. C550-C562
Closed Access | Times Cited: 10
Ultra-Fast Multi-Organ Proteomics Unveils Tissue-Specific Mechanisms of Drug Efficacy and Toxicity
Yun Xiong, Lin Tan, Waikin Chan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 3
Asparagine availability controls germinal center B cell homeostasis
Yavuz F. Yazicioglu, Eros Marin, Hana F. Andrew, et al.
Science Immunology (2024) Vol. 9, Iss. 102
Closed Access | Times Cited: 3
Asparagine transport through SLC1A5/ASCT2 and SLC38A5/SNAT5 is essential for BCP‐ALL cell survival and a potential therapeutic target
Giuseppe Taurino, Erica Dander, Martina Chiu, et al.
British Journal of Haematology (2024) Vol. 205, Iss. 1, pp. 175-188
Closed Access | Times Cited: 2
UCP2 silencing restrains leukemia cell proliferation through glutamine metabolic remodeling
Tiphaine Sancerni, Ophélie Renoult, Angèle Luby, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Advances in human glutamine-hydrolyzing synthetases and their therapeutic potential
Wen Zhu, Alanya J. Nardone, Lucciano A. Pearce
Frontiers in Chemical Biology (2024) Vol. 3
Open Access | Times Cited: 1
A human-like glutaminase-free asparaginase is highly efficacious in ASNS leukemia and solid cancer mouse xenograft models
Maaike Van Trimpont, Amanda M. Schalk, Kenneth Hofkens, et al.
Cancer Letters (2024), pp. 217404-217404
Open Access | Times Cited: 1
Molecular and cellular mechanisms of chemoresistance in paediatric pre–B cell acute lymphoblastic leukaemia
Caleb B. Lill, Stephen Fitter, Andrew C.W. Zannettino, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 4, pp. 1385-1399
Open Access | Times Cited: 1
Tamoxifen resistance-related ceRNA network for breast cancer
Zipeng Qiao, Yu Xing, Qingquan Zhang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 6
A metabolic synthetic lethality of PI3K-driven cancer
Vahid Asnafi, Guillaume P. Andrieu, Mathieu Simonin, et al.
Research Square (Research Square) (2024)
Open Access
Production Process Optimization of Recombinant Erwinia carotovora l-Asparaginase II in Escherichia coli Fed-Batch Cultures and Analysis of Antileukemic Potential
Bruna Coelho de Andrade, Gaby Renard, Adriano Gennari, et al.
ACS Omega (2024) Vol. 9, Iss. 32, pp. 34951-34963
Open Access
Asparagine availability controls B cell homeostasis
Yavuz F. Yazicioglu, Eros Marin, Hana F. Andrew, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Page 1

Scroll to top